Published in Cancer Epidemiol Biomarkers Prev on June 01, 2009
Adolescent and adult risk factors for testicular cancer. Nat Rev Urol (2012) 1.22
Increased Black-White disparities in mortality after the introduction of lifesaving innovations: a possible consequence of US federal laws. Am J Public Health (2010) 1.05
Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004. Cancer Epidemiol Biomarkers Prev (2011) 0.99
Health-related characteristics and dietary intakes of male veterans and non-veterans in the Multiethnic Cohort Study (United States). J Mil Veterans Health (2011) 0.89
Significance of infectious agents in colorectal cancer development. J Cancer (2013) 0.85
Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions. J Cancer (2013) 0.82
Melanoma incidence rates among whites in the U.S. Military. Cancer Epidemiol Biomarkers Prev (2010) 0.80
Prospective Analysis of Health and Mortality Risk in Veteran and Non-Veteran Participants in the Women's Health Initiative. Womens Health Issues (2015) 0.78
Trends in testicular germ cell tumors among U.S. military servicemen, 1990-2003. Mil Med (2011) 0.78
Oral contraceptive use among women in the military and the general U.S. population. J Womens Health (Larchmt) (2010) 0.77
Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments. J Urol (2011) 0.75
Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol (2008) 4.72
International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer (2005) 3.81
Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer (2005) 3.51
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer (2004) 2.46
Trends in the incidence of testicular germ cell tumors in the United States. Cancer (2003) 2.45
Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev (2001) 2.14
Lung cancer trends in young adults: an early indicator of progress in tobacco control (United States). Cancer Causes Control (2003) 2.02
Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med (2004) 2.00
Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 1.95
Substance use trends among active duty military personnel: findings from the United States Department of Defense Health Related Behavior Surveys, 1980-2005. Addiction (2007) 1.95
Epidemiology of breast cancer in young women. Breast Dis (2006) 1.63
Breast cancer trends among black and white women in the United States. J Clin Oncol (2005) 1.60
Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev (2006) 1.55
Standardized comparisons of the use of alcohol, drugs, and cigarettes among military personnel and civilians. Am J Public Health (1991) 1.45
Comparing tobacco use among incoming recruits and military personnel on active duty in the United States. Tob Control (1998) 1.44
Trends in testicular germ cell tumours by ethnic group in the United States. Int J Androl (2007) 1.16
Cancer mortality among workers exposed to chemicals during uranium processing. J Occup Environ Med (1999) 1.03
Cancer incidence in the U.S. Air Force: 1989-2002. Aviat Space Environ Med (2006) 1.02
Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst (1991) 0.96
Papanicolaou testing among women in the southern United States. J Womens Health (Larchmt) (2008) 0.91
Smokeless tobacco use in military personnel. Mil Med (2007) 0.91
Risk of breast cancer among enlisted Army women occupationally exposed to volatile organic compounds. Am J Ind Med (2005) 0.89
Prediction of adult-onset smoking initiation among U.S. Air force recruits using the pierce susceptibility questionnaire. Am J Prev Med (2005) 0.89
Contribution of occupational factors to current smoking among active-duty U.S. Navy careerists. Nicotine Tob Res (2008) 0.87
Increased incidence of testicular cancer in active duty members of the Department of Defense. Urology (1999) 0.87
Prostatic intraepithelial neoplasia: an overview. Rev Urol (2005) 0.85
The risks of oral contraceptive pills. Semin Reprod Med (2001) 0.79
Radon as a risk factor for extra-pulmonary tumours. Med Oncol Tumor Pharmacother (1993) 0.78
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med (2005) 12.46
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ (2004) 7.92
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med (2003) 6.06
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00
Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25
Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev (2007) 4.23
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst (2005) 4.14
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (2010) 3.98
Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol (2006) 3.79
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2012) 3.69
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood (2011) 3.30
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology (2005) 3.24
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol (2008) 3.21
Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst (2006) 3.17
Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol (2005) 3.01
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer (2012) 2.95
Outcomes of endodontic therapy in general practice: a study by the Practitioners Engaged in Applied Research and Learning Network. J Am Dent Assoc (2012) 2.90
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol (2005) 2.85
Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol (2008) 2.80
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer (2006) 2.73
Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst (2008) 2.72
Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst (2004) 2.60
A quantitative approach for estimating exposure to pesticides in the Agricultural Health Study. Ann Occup Hyg (2002) 2.60
Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat (2005) 2.57
Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol (2010) 2.53
Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice. Heart (2010) 2.51
Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev (2009) 2.50
Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics (2003) 2.49
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid (2010) 2.48
US lung cancer trends by histologic type. Cancer (2014) 2.46
Trends in the incidence of testicular germ cell tumors in the United States. Cancer (2003) 2.45
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol (2003) 2.40
Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst (2009) 2.33
Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer (2011) 2.23
Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol (2009) 2.20
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
Breast cancer adjuvant therapy: time to consider its time-dependent effects. J Clin Oncol (2011) 2.16
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood (2009) 2.16
Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study. Hepatology (2014) 2.14
Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood (2010) 2.12
AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood (2010) 2.10
International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev (2010) 2.07
Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era. J Clin Oncol (2003) 2.06
Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat (2002) 2.04
Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med (2004) 2.00
Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol (2007) 1.97
A geographic analysis of prostate cancer mortality in the United States, 1970-89. Int J Cancer (2002) 1.94
Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis (2007) 1.94
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol (2004) 1.91
Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer (2003) 1.85
Rising prostate cancer rates in South Korea. Prostate (2006) 1.83
Early breast cancer. Lancet (2009) 1.82
Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst (2010) 1.81
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78
Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes. Cancer Res (2010) 1.77
Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke (2003) 1.76
Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol (2010) 1.76
Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet (2013) 1.74
Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer (2008) 1.74
Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73
Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control (2003) 1.72
Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol (2004) 1.71
Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 1.68
Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology (2012) 1.68
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol (2011) 1.67
Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat (2004) 1.67
Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol (2004) 1.65
The global breast cancer burden. Future Oncol (2012) 1.64